• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 3. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 4. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Phenol ethers
• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers

Introduction to (1R)-1-(3-ethoxyphenyl)ethan-1-amine and Its Significance in Modern Chemical Research

CAS No. 263893-81-8 corresponds to the chiral amine compound (1R)-1-(3-ethoxyphenyl)ethan-1-amine, a molecule that has garnered considerable attention in the field of pharmaceutical chemistry and medicinal biology. This compound, characterized by its specific stereochemistry and functional groups, holds promise for various applications, particularly in the development of novel therapeutic agents. The unique structural features of this amine make it a valuable scaffold for further chemical modifications and biological evaluations.

The (1R)-configuration of the amine at the chiral center is crucial for its pharmacological properties, influencing both its binding affinity and metabolic stability. This stereochemical specificity is often a key factor in the design of drugs that target specific biological pathways with high selectivity. The presence of the 3-ethoxyphenyl moiety further enhances the compound's potential by introducing hydrophobic interactions and electronic effects that can modulate its biological activity.

In recent years, there has been a growing interest in exploring the pharmacological potential of amine derivatives, particularly those with complex aromatic substituents. Research has demonstrated that compounds like (1R)-1-(3-ethoxyphenyl)ethan-1-amine can exhibit a range of biological activities, including anti-inflammatory, analgesic, and even anticancer properties. These findings are supported by both in vitro and in vivo studies, which have highlighted the compound's ability to interact with various biological targets.

One of the most compelling aspects of this compound is its versatility as a building block for drug discovery. The chiral center allows for the synthesis of enantiomerically pure forms, which can be critical for achieving desired pharmacological outcomes while minimizing off-target effects. Additionally, the ethoxyphenyl group provides a handle for further chemical modifications, enabling researchers to fine-tune the properties of the molecule to optimize its therapeutic potential.

The synthesis of (1R)-1-(3-ethoxyphenyl)ethan-1-amine involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and enantioselectivity. Advanced synthetic methodologies, such as asymmetric hydrogenation and chiral resolution techniques, have been employed to achieve the desired stereochemical purity. These synthetic strategies not only highlight the technical prowess of modern chemical research but also underscore the importance of robust methodologies in producing biologically active compounds.

Recent advancements in computational chemistry have further enhanced our understanding of how (1R)-1-(3-ethoxyphenyl)ethan-1-amine interacts with biological targets. Molecular modeling studies have revealed insights into its binding mode and affinity for various receptors, providing a rational basis for designing more effective derivatives. These computational approaches complement experimental efforts by offering predictive insights into structure-activity relationships, thereby accelerating the drug discovery process.

The biological evaluation of this compound has shown promising results in preclinical models, particularly in contexts where modulation of neurotransmitter systems is relevant. For instance, studies suggest that derivatives of this molecule may exhibit properties similar to those of known psychoactive agents, although further research is needed to fully elucidate their mechanisms of action. Such findings open up new avenues for exploring treatments for neurological and psychiatric disorders.

In conclusion, (1R)-1-(3-ethoxyphenyl)ethan-1-amine (CAS No. 263893-81-8) represents a significant advancement in pharmaceutical chemistry due to its unique structural features and potential biological activities. Its chiral configuration and aromatic substituents make it an attractive candidate for further development into novel therapeutic agents. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in addressing unmet medical needs across various therapeutic areas.

• 104294-63-5(1-(4-Ethoxyphenyl)ethanamine)
• 1108684-07-6((1S)-1-(4-ethoxyphenyl)ethan-1-amine)
• 925650-26-6(1-(3-Propoxyphenyl)ethanamine)
• 1213547-94-4((1S)-1-(3-ethoxyphenyl)ethanamine;hydrochloride)
• 856758-56-0((1R)-1-(4-ethoxyphenyl)ethan-1-amine)
• 860701-75-3(1-(4-propoxyphenyl)ethylamine Hydrochloride)
• 943114-70-3(1-[4-(2-Methoxy-ethoxy)-phenyl]-ethylamine)
• 1213097-29-0((R)-1-(3-Ethoxyphenyl)ethanamine hydrochloride)
• 603945-50-2(1-(3-Ethoxyphenyl)ethanamine)
• 856562-89-5((1R)-1-(4-ethoxyphenyl)ethanamine;hydrochloride)